Metsera Stock Rises Following Pfizer Acquisition Agreement
Written by Ohris M. Greyoon, Blockchain & Crypto Expert
Source: Coinmarketcap
Updated: Sep 22 2025Pfizer's Acquisition of Metsera: Pfizer announced its acquisition of Metsera, Inc. for $4.9 billion, which includes a payment of $47.50 per share and contingent value rights linked to milestones, aimed at enhancing its presence in the obesity treatment market.
Market Reaction: Following the announcement, Metsera's shares surged over 62%, reflecting strong investor confidence and institutional support, with the stock price reaching $53.99.
About the author
Ohris M. Greyoon
Ohris M. Greyoon holds a Master’s in Computer Science from MIT and has 10 years of experience in blockchain technology and cryptocurrency markets. A pioneer in decentralized finance (DeFi) analysis, he leads Intellectia’s Crypto News, offering cutting-edge insights into digital assets.
